Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cipla
Fish and Richardson
Citi
Mallinckrodt
AstraZeneca
Colorcon
Farmers Insurance
US Department of Justice
Moodys

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,029,768

« Back to Dashboard

Summary for Patent: 8,029,768
Title:Treatment of respiratory diseases
Abstract: A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
Inventor(s): Bannister; Robin Mark (Essex, GB), McGlashan Richards; Andrew John (Cambridge, GB), Gilbert; Julian Clive (Essex, GB), Morton; David A. V. (Bath, GB), Staniforth; John (Bath, GB)
Assignee: Sosei R&D Ltd. (Essex, GB)
Application Number:12/048,812
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Drugs Protected by US Patent 8,029,768

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sunovion Pharms Inc SEEBRI glycopyrrolate POWDER;INHALATION 207923-001 Oct 29, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial LONG - TERM MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ➤ Try a Free Trial
Sunovion Pharms Inc UTIBRON glycopyrrolate ; indacaterol maleate POWDER;INHALATION 207930-001 Oct 29, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial LONG - TERM MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,029,768

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0008660.3Apr 7, 2000

Non-Orange Book US Patents Family Members for Patent 8,029,768

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,871,274 Pharmaceutical formulations for dry powder inhalers ➤ Try a Free Trial
9,566,239 Pharmaceutical formulations for dry powder inhalers ➤ Try a Free Trial
6,884,794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets ➤ Try a Free Trial
7,368,104 Treatment of respiratory diseases ➤ Try a Free Trial
8,101,160 Formulations for use in inhaler devices ➤ Try a Free Trial
9,585,839 Particles for use in a pharmaceutical composition ➤ Try a Free Trial
8,580,306 Particles for use in a pharmaceutical composition ➤ Try a Free Trial
7,541,022 Pharmaceutical formulations for dry powder inhalers ➤ Try a Free Trial
7,744,855 Method of making particles for use in a pharmaceutical composition ➤ Try a Free Trial
8,182,791 Formulations for use in inhaler devices ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,029,768

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 330585 ➤ Try a Free Trial
Austria 339195 ➤ Try a Free Trial
Austria 348603 ➤ Try a Free Trial
Austria 364381 ➤ Try a Free Trial
Austria 377416 ➤ Try a Free Trial
Austria 378039 ➤ Try a Free Trial
Austria 382335 ➤ Try a Free Trial
Austria 446085 ➤ Try a Free Trial
Austria 513542 ➤ Try a Free Trial
Austria 517607 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Covington
Merck
Fish and Richardson
US Department of Justice
AstraZeneca
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot